Alnivo Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Alnivo Therapeutics General Information

Description

Operator of a biotechnology company designed to be focused on the therapeutic potential of Heat-Shock Protein for cosmetic and therapeutic purposes. The company's capabilities lie in extending the lifespan of heat-shock protein, unlocking its therapeutic possibilities for various applications, including skin repair, wound healing, scar reduction, aging, nerve repair, and fibrosis treatment, enabling patients to enhance their lives and promote well-being

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 241 Francis Avenue
  • Mansfield, MA 02048
  • United States
+1 (617)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 241 Francis Avenue
  • Mansfield, MA 02048
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alnivo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 30-Oct-2025 Completed Generating Revenue
To view Alnivo Therapeutics’s complete valuation and funding history, request access »

Alnivo Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bioincubator Accelerator/Incubator
To view Alnivo Therapeutics’s complete investors history, request access »

Alnivo Therapeutics FAQs

  • When was Alnivo Therapeutics founded?

    Alnivo Therapeutics was founded in 2020.

  • Where is Alnivo Therapeutics headquartered?

    Alnivo Therapeutics is headquartered in Mansfield, MA.

  • What industry is Alnivo Therapeutics in?

    Alnivo Therapeutics’s primary industry is Biotechnology.

  • Is Alnivo Therapeutics a private or public company?

    Alnivo Therapeutics is a Private company.

  • What is Alnivo Therapeutics’s current revenue?

    The current revenue for Alnivo Therapeutics is .

  • Who are Alnivo Therapeutics’s investors?

    Bioincubator has invested in Alnivo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process